For decades, a routine blood test has measured each person against a universal standard — a shared definition of normal that belongs to no one in particular. Researchers at Mass General Brigham have now published findings in Nature suggesting that each healthy person carries their own stable biological baseline, one so distinct it can be distinguished from nearly all others. The implication is quiet but profound: the earliest signs of diabetes, heart disease, or kidney failure may already be visible in the data we collect, if only we learn to read it against the right reference — the patient t
Personalized blood test setpoints could revolutionize early disease detection
Your blood test compared to yourself, not to millions of strangers
Mark
So the study is saying that the normal range for a blood test isn't actually normal for everyone?
Mimi
Exactly. Right now, labs use the same reference range for everyone—say, red blood cells between 4.5 and 5.5 million per microliter. But the research suggests each person has their own stable setpoint, and what's normal for you might be 4.7, while for someone else it's 5.2.
Luke
But wait—how do they know these setpoints are stable? Did they follow the same people over years?
Mimi
The study was retrospective, so they looked at existing data. They found that individual setpoints appear consistent over time, but Luke's right to push back—the study design means we're looking at patterns in historical records, not a prospective follow-up.
Mark
If my setpoint is different from the standard range, wouldn't my doctor already know something was off?
Mimi
Not necessarily. You might fall within the standard range but still be meaningfully different from your own baseline. That shift could signal early disease, but it would be invisible under the current system.
Luke
The study claims two- to four-fold risk stratification for multiple diseases. But which diseases? How many patients were in the analysis? Those details matter for understanding how robust this finding actually is.
Mimi
The paper is in Nature, so it's been peer-reviewed, but you're right that the specifics about sample size and which conditions showed the strongest signal would help readers understand the scope.
Mark
So what happens next? Do hospitals start tracking individual setpoints?
Mimi
That's the open question. The infrastructure exists—they already have the blood data. It's more about changing how clinicians interpret it. But that requires education, buy-in, and probably some validation in prospective studies.
Luke
And there's a practical question: if everyone has a unique setpoint, how do you establish what that setpoint is for a new patient? You need baseline data first.
Mimi
Exactly. You'd need at least one or two prior tests to establish the pattern. For someone coming in for the first time, you'd still rely on standard ranges until you build their personal history.
O Pulso
- Standard blood count ranges, used for millions of patients, may be masking early disease signals hiding in plain sight within otherwise 'normal' results.
- Each healthy person's blood measures fluctuate around a personal setpoint so unique it differs meaningfully from 98% of other healthy adults — a fact current clinical practice largely ignores.
- Personalized setpoints deliver two- to four-fold risk stratification for conditions like diabetes, heart disease, and kidney failure, rivaling the predictive power of established screening tools.
- Researchers stress no new tests are needed — the same blood draws already taken could be reinterpreted through a personalized lens to catch meaningful shifts before symptoms emerge.
- The path forward points toward a precision medicine model where a patient's own history becomes the benchmark, potentially transforming how early-stage disease is identified in apparently healthy adults.
For decades, a routine blood test has measured each person against a universal standard — a shared definition of normal that belongs to no one in particular. Researchers at Mass General Brigham have now published findings in Nature suggesting that each healthy person carries their own stable biological baseline, one so distinct it can be distinguished from nearly all others. The implication is quiet but profound: the earliest signs of diabetes, heart disease, or kidney failure may already be visible in the data we collect, if only we learn to read it against the right reference — the patient themselves.
When a doctor orders a complete blood count, the results are measured against a universal reference range — the same band of values applied to millions of patients worldwide. Fall within it, and you're told everything looks normal. But a new study from Mass General Brigham, published in Nature, challenges that assumption at its foundation.
The researchers found that each person carries a stable, individual setpoint — a characteristic biological baseline around which their blood values naturally orbit. Shaped by genetics, age, and health history, these setpoints are remarkably consistent within a single person over time, yet vary so significantly between people that any one individual's baseline can be distinguished from roughly 98% of other healthy adults. The current one-size-fits-all approach, the study suggests, may cause clinicians to overlook meaningful changes simply because a patient's shifted values still fall within the population-wide normal band.
Senior author John Higgins of Massachusetts General Hospital's Center for Systems Biology noted that this long-term individual stability opens new possibilities for precision medicine — particularly for catching disease before it announces itself. First author Brody Foy, now at the University of Washington, found that personalized setpoints offer two- to four-fold relative risk stratification for conditions like diabetes, heart disease, and kidney failure, a predictive power comparable to established screening tools.
Critically, the approach requires no new technology. The same blood draws already being collected could be reanalyzed through a personalized lens, flagging when a patient's values have drifted from their own baseline rather than from a stranger's average. The question the study leaves open is whether clinical medicine will follow where the data now points.
Your doctor orders a complete blood count. It's routine, something most physicians request for any adult who comes in for a checkup. A single vial of blood gets analyzed, and within hours you have numbers: red blood cell count, white blood cell count, hemoglobin, platelets. The lab compares these numbers to a reference range—the same range used for millions of other patients. If your values fall within that band, you're told everything looks normal. If they fall outside, something might be wrong.
But what if normal is not a fixed target? What if the healthy baseline for your blood is fundamentally different from the healthy baseline for someone else—so different that your personal setpoint might be distinguishable from 98 percent of other healthy adults? That is the finding of a new study from researchers at Mass General Brigham, published in Nature, and it suggests that the way we interpret blood tests may need to change.
The researchers conducted a retrospective analysis of complete blood count data and discovered something that challenges decades of clinical practice: each person appears to have their own stable setpoint—a characteristic value around which their blood measures naturally fluctuate. These setpoints are shaped by genetics, disease history, and age, but they are remarkably consistent within an individual over time. The current one-size-fits-all reference intervals, the study suggests, can cause clinicians to miss meaningful deviations in a patient's health because they are comparing apples to a standardized apple when they should be comparing apples to that particular apple's own baseline.
John Higgins, the senior author and a physician at Massachusetts General Hospital's Center for Systems Biology, framed the implication plainly: complete blood counts vary substantially from person to person even among completely healthy individuals, and a more personalized approach could reveal insights that a universal standard cannot. The long-term stability of these individual setpoints, he noted, opens new possibilities for precision medicine in managing healthy adults—and potentially in catching disease before it announces itself.
The practical consequence is significant. By tracking a patient's own setpoint rather than comparing them to a population average, clinicians might diagnose diseases in their early stages among people who appear otherwise well. Diabetes, heart disease, kidney failure—all conditions that benefit enormously from early intervention—could potentially be caught sooner. Brody Foy, the study's first author and now a faculty member at the University of Washington, found that personalized setpoints produce a two- to four-fold relative risk stratification for multiple diseases, a level of predictive power comparable to established disease screening factors.
The researchers emphasize that this is not about replacing current blood tests but about interpreting them differently. The same CBC data already being collected could be analyzed through a personalized lens, allowing clinicians to identify when a patient's values have shifted meaningfully from their own baseline—even if those shifted values still fall within the standard reference range. This could inform decisions about whether additional screening is warranted and help shape more targeted treatment plans tailored to individual biology rather than population averages.
The study opens a door to a different kind of medicine: one where your blood test is compared not to millions of strangers but to yourself. The question now is whether clinical practice will follow.
Citações Notáveis
Complete blood counts vary substantially from person to person even when completely healthy, and a more personalized approach could give more insight into a person's health or disease.— John Higgins, MD, Center for Systems Biology, Massachusetts General Hospital
Quer a matéria completa?
Leia o original em News-Medical.net ↗
Health & Medicine